SHC
Sotera Health Co
-0.09 (-0.49%)19.24USD437K成交股數5.5B市值33.8本益比(近四季)4.5股價營收比+9.2%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 321M+26% | 280M-4% | 311M+9% | 294M+6% | 255M+3% | 290M+10% | 285M+12% | 277M+25% | 248M | 263M | 255M | 221M |
| 營業成本 | 143M | 133M | 134M | 128M | 119M | 126M | 127M | 124M | 121M | 117M | 116M | 109M |
| 毛利 | 178M+31% | 147M-11% | 178M+12% | 167M+9% | 135M+7% | 164M+13% | 158M+13% | 153M+37% | 127M | 146M | 140M | 112M |
| 毛利率 | 55.4% | 52.5% | 57.0% | 56.6% | 53.2% | 56.6% | 55.4% | 55.2% | 51.2% | 55.5% | 54.7% | 50.5% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 68.2M | 68.2M | 63.3M | 68.9M | 63.1M | 61.8M | 62.0M | 60.6M | 58.2M | 54.1M | 60.3M | 61.9M |
| 營業利益 | – | – | – | – | – | 87.1M+15% | 80.5M+27% | 76.8M+130% | 53.2M | 76.1M | 63.2M | 33.4M |
| 營業利益率 | – | – | – | – | – | 30.0% | 28.2% | 27.8% | 21.4% | 28.9% | 24.8% | 15.1% |
| 稅後淨利 | 53.6M-505% | 26.6M+116% | 48.4M+185% | 8.0M-9% | −13.3M-310% | 12.3M-190% | 17.0M-28% | 8.8M+208% | 6.3M | −13.7M | 23.5M | 2.8M |
| 淨利率 | 16.7% | 9.5% | 15.5% | 2.7% | -5.2% | 4.2% | 6.0% | 3.2% | 2.5% | -5.2% | 9.2% | 1.3% |
| 稀釋 EPS | 0.19-480% | 0.09+80% | 0.17+183% | 0.030% | -0.05-350% | 0.05-200% | 0.06-25% | 0.03+200% | 0.02 | -0.05 | 0.08 | 0.01 |
| 稀釋股數 | 288M | 288M | 287M | 286M | 284M | 285M | 286M | 285M | 284M | 281M | 283M | 283M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 357M | 314M | 299M | 332M | 304M | 277M | 307M | 246M | 261M | 245M | 263M | 648M |
| 應收帳款 | 151M | 137M | 142M | 137M | 128M | 140M | 130M | 124M | 111M | 118M | 117M | 109M |
| 存貨 | 56.4M | 57.5M | 49.9M | 59.9M | 61.0M | 49.2M | 53.6M | 57.9M | 51.3M | 37.9M | 42.1M | 46.7M |
| 總資產 | 3.3B | 3.2B | 3.2B | 3.2B | 3.1B | 3.1B | 3.1B | 3.1B | 3.1B | 3.0B | 3.1B | 3.4B |
| 有息負債 | 2.1B | 2.1B | 2.1B | 2.2B | 2.2B | 2.2B | 2.2B | 2.2B | 2.2B | 2.2B | 2.2B | 2.2B |
| 總負債 | 2.6B | 2.6B | 2.6B | 2.7B | 2.7B | 2.7B | 2.7B | 2.6B | 2.6B | 2.7B | 2.7B | 3.1B |
| 股東權益 | 666M | 623M | 550M | 511M | 414M | 405M | 470M | 423M | 429M | 377M | 418M | 361M |
| 負債比 | 79.9% | 80.8% | 82.7% | 84.1% | 86.6% | 86.8% | 85.1% | 86.2% | 86.0% | 87.6% | 86.4% | 89.4% |
| 淨現金(現金 − 有息負債) | −1.8B | −1.8B | −1.8B | −1.9B | −1.9B | −1.9B | −1.9B | −2.0B | −2.0B | −2.0B | −2.0B | −1.6B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 29.4M | – | – | 55.5M+472% | – | – | – | 9.7M | – | – | 33.9M |
| 資本支出 | – | 46.2M | – | – | 19.9M | – | – | – | 34.9M | – | – | 45.0M |
| 自由現金流 | – | −16.7M | – | – | 35.6M-241% | – | – | – | −25.2M | – | – | −11.1M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -6.0% | – | – | 14.0% | – | – | – | -10.2% | – | – | -5.0% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.2B
| Sterigenics | 756M | 65.0% | +8.3% |
|---|---|---|---|
| Nelson Labs | 220M | 18.9% | -3.9% |
| Nordion | 188M | 16.1% | +8.2% |
地區2025 年度 · 1.2B
| 美國 | 630M | 54.1% | +2.1% |
|---|---|---|---|
| 歐洲 | 232M | 20.0% | +18.5% |
| 加拿大 | 222M | 19.1% | +6.3% |
| Other Geographical Areas | 79.9M | 6.9% | +1.4% |
產品／服務2025 年度 · 1.2B
| 服務 | 996M | 85.6% | +5.7% |
|---|---|---|---|
| 產品 | 168M | 14.4% | +5.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.2B | +5.7% | 77.9M | 6.7% | 0.27 | 149M |
| FY2024 | 1.1B | +4.9% | 44.4M | 4.0% | 0.16 | 45.1M |
| FY2023 | 1.0B | +4.5% | 51.4M | 4.9% | 0.18 | −363M |
| FY2022 | 1.0B | +7.8% | −234M | -23.3% | -0.83 | 95.6M |
| FY2021 | 931M | +13.9% | 116M | 12.5% | 0.41 | 179M |
| FY2020 | 818M | +5.1% | −38.6M | -4.7% | -0.16 | 67.1M |
| FY2019 | 778M | – | −20.9M | -2.7% | -0.09 | 91.8M |